ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
iX Biopharma Reports on Outcome of Wafermine End-of-phase 2 Meeting with US FDA
December 16, 2019Specialty pharmaceutical company iX Biopharma Ltd (SGX:42C) ("iX Biopharma" or, "the Company") is pleased to announce that it has successfully concluded an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) regarding Wafermine, a subl
Pharma Sources Insight January 2025
